BeStock  
Stocks › Biotechnology › PBYI

Puma Biotechnology PBYI

US equityMarket cap rank #3692Biotechnology
$7.05 −$0.07 (-0.98%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $7.05 0.00%
Open$7.05
Prev close$7.12
Day range$6.91 – $7.22
Volume861.2K
Market cap$364.47M
P/E (TTM)15.3
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$55.06M+1.1% YoY
Operating profit$5.27M-44.9% YoY
Net profit$5.96M-32.7% YoY
Diluted EPS$0.11-35.3% YoY
Free cash flow$14.58M+50.9% YoY
Operating cash flow$14.58M

Revenue, last 8 quarters

$59.1MDec '24$46.0MMar '25$52.4MJun '25$54.5MSep '25$75.5MDec '25$44.8MMar '26$56.5MJun '26$55.1MSep '26

Net profit, last 8 quarters

$19.3MDec '24$3.0MMar '25$5.9MJun '25$8.8MSep '25$13.4MDec '25$-3.8MMar '26$8.2MJun '26$6.0MSep '26

Diluted EPS by quarter

0.39Dec '240.06Mar '250.12Jun '250.17Sep '250.26Dec '25-0.07Mar '260.16Jun '260.11Sep '26

Free cash flow by quarter

$15.6MDec '24$3.6MMar '25$14.1MJun '25$9.7MSep '25$14.5MDec '25$15.4MMar '26$1.6MJun '26$14.6MSep '26

Annual revenue

$225.1MFY20$253.2MFY21$228.0MFY22$235.6MFY23$230.5MFY24$228.4MFY25

Profitability & balance sheet

Gross margin73.6%
Operating margin11.3%
Net margin10.3%
Return on equity18.2%
Return on assets11.7%
Return on invested capital14.6%
Current ratio3.03
Liabilities / assets27.7%
Cash & investments$108.58M
Total debt$4.18M
Net cash (debt)$104.39M
Free cash flow / sales19.9%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $55.06M $56.50M $44.81M $228.37M $75.45M
Total Operating Revenue $55.06M $56.50M $44.81M $228.37M $75.45M
Cost of Revenue $15.20M $12.48M $10.42M $58.16M $23.13M
Gross Profit $39.86M $44.03M $34.39M $170.21M $52.33M
Operating Expense $34.58M $36.44M $38.22M $132.92M $35.22M
Selling and Admin Expenses $16.30M $17.55M $18.42M $71.21M $18.38M
-General & Admin Expense $16.30M $17.55M $18.42M $71.21M $18.38M
Research & Development $18.28M $18.90M $19.80M $62.07M $16.84M
Asset Impairment Loss $0.00 $0.00 $0.00 -$362,000.00 $0.00
Operating Profit $5.27M $7.59M -$3.83M $37.30M $17.11M
Net Non-Operating Interest Income (Expense) $879,000.00 $651,000.00 $271,000.00 -$2.54M -$142,000.00
Non-Operating Interest Income $879,000.00 $831,000.00 $1.00M $4.08M $977,000.00
Non-Operating Interest Expense $0.00 $180,000.00 $731,000.00 $6.62M $1.12M
Other Income (Expense) $19,000.00 $9,000.00 $130,000.00 $1.03M $143,000.00
Other Non-Operating Income (Expenses) $19,000.00 $9,000.00 $130,000.00 $1.03M $143,000.00
Pretax Profit $6.17M $8.25M -$3.43M $35.78M $17.11M
Tax $216,000.00 $56,000.00 $326,000.00 $4.67M $3.67M
Net Profit $5.96M $8.19M -$3.75M $31.11M $13.44M
Profit from Continuing Operations $5.96M $8.19M -$3.75M $31.11M $13.44M
Net Income to Parent Company $5.96M $8.19M -$3.75M $31.11M $13.44M
Net Income to Common Stockholders $5.96M $8.19M -$3.75M $31.11M $13.44M
Basic EPS $0.12 $0.16 -$0.07 $0.62 $0.27
Diluted EPS $0.11 $0.16 -$0.07 $0.61 $0.26

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $202.77M $192.74M $192.70M $216.30M $216.30M
Total Current Assets $157.63M $145.07M $142.26M $162.69M $162.69M
Cash and Cash Equivalents & Short-Term Investments $108.58M $93.90M $101.55M $97.53M $97.53M
-Cash and Cash Equivalents $41.55M $36.54M $36.19M $29.64M $29.64M
-Short Term Investments $67.03M $57.37M $65.35M $67.89M $67.89M
Receivables $32.83M $34.06M $26.33M $53.65M $53.65M
-Accounts Receivable $32.83M $34.06M $26.33M $53.65M $53.65M
Prepaid Assets $2.84M $2.00M $1.69M $1.99M $1.99M
Inventory $11.49M $13.32M $8.69M $5.52M $5.52M
Restricted Cash $0.00 $0.00 $2.09M $2.09M $2.09M
Other Current Assets $1.90M $1.79M $1.91M $1.91M $1.91M
Total Non-Current Assets $45.14M $47.66M $50.44M $53.62M $53.62M
Net PPE $4.35M $4.52M $4.70M $5.56M $5.56M
-Gross PPE $7.28M $7.43M $7.59M $10.16M $10.16M
-Accumulated Depreciation -$2.93M -$2.91M -$2.89M -$4.60M -$4.60M
Non-Current Prepaid Assets $97,000.00 $97,000.00 $97,000.00 $101,000.00 $101,000.00
Goodwill and Other Intangible Assets $34.09M $36.52M $38.96M $41.39M $41.39M
-Other Intangible Assets $34.09M $36.52M $38.96M $41.39M $41.39M
Non-Current Deferred Assets $3.83M $3.83M $3.83M $3.83M $3.83M
Other Non-Current Assets $2.77M $2.69M $2.86M $2.73M $2.73M
Total Liabilities $56.15M $54.19M $64.28M $85.96M $85.96M
Total Current Liabilities $51.97M $49.83M $59.74M $81.25M $81.25M
Payables $5.06M $3.11M $8.17M $5.06M $5.06M
-Accounts Payable $5.06M $3.11M $8.17M $5.06M $5.06M
Current Accrued Expenses $34.30M $35.99M $31.16M $35.86M $35.86M
Short-Term Debt and Capital Lease Obligation $683,000.00 $450,000.00 $11.41M $23.84M $23.84M
-Current Capital Lease Obligation $683,000.00 $450,000.00 $125,000.00 $1.31M $1.31M
Other Current Liabilities $683,000.00 $1.14M $1.79M $2.33M $2.33M
Total Non-Current Liabilities $4.18M $4.37M $4.55M $4.71M $4.71M
Long Term Debt and Capital Lease Obligation $4.18M $4.37M $4.55M $4.71M $4.71M
-Long Term Capital Lease Obligation $4.18M $4.37M $4.55M $4.71M $4.71M
Total Equity $146.61M $138.54M $128.42M $130.34M $130.34M
Stockholders' Equity $146.61M $138.54M $128.42M $130.34M $130.34M
Capital Stock $5,000.00 $5,000.00 $5,000.00 $5,000.00 $5,000.00
-Common Stock $5,000.00 $5,000.00 $5,000.00 $5,000.00 $5,000.00
Additional Paid-In Capital $1.42B $1.42B $1.42B $1.41B $1.41B
Retained Earnings -$1.27B -$1.28B -$1.29B -$1.28B -$1.28B
Gains/Losses Not Affecting Retained Earnings -$98,000.00 -$45,000.00 -$31,000.00 $36,000.00 $36,000.00
-Current Debt – – $11.28M $22.52M $22.52M
Non-Current Accrued Expenses – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $14.58M $1.62M $15.42M $41.80M $14.42M
Net cash flow from continuing operations $14.58M $1.62M $15.42M $41.80M $14.42M
Net Income from Continuing Operations $5.96M $8.19M -$3.75M $31.11M $13.44M
Gain/Loss from Continuing Operations $0.00 $0.00 $6,000.00 $4,000.00 $0.00
Depreciation & Depletion & Amortization $2.45M $2.52M $2.58M $10.94M $2.66M
Change in Working Capital $4.15M -$11.03M $14.68M -$10.08M -$6.54M
-Change in Receivables $1.23M -$7.73M $27.33M -$21.28M -$20.09M
-Change in Inventory $1.83M -$4.63M -$3.18M $3.21M $3.96M
-Change in Prepaid Assets -$1.05M -$15,000.00 $116,000.00 -$325,000.00 -$718,000.00
-Change in Payables and Accrued Expense $2.37M $1.59M -$8.58M $12.70M $11.55M
-Change in Other Current Assets $25,000.00 -$3,000.00 $60,000.00 -$165,000.00 -$26,000.00
-Change in Other Current Liabilities -$457,000.00 -$544,000.00 -$503,000.00 -$2.41M -$672,000.00
-Change In Other Working Capital $200,000.00 $300,000.00 -$553,000.00 -$1.81M -$539,000.00
Net cash flow from investing -$9.71M $7.97M $2.47M -$36.19M -$26.98M
Net Cash Flow from Continuing Investing Activities -$9.71M $7.97M $2.47M -$36.19M -$26.98M
Net PPE Purchase and Sale $0.00 $0.00 $0.00 -$71,000.00 $36,000.00
Net Investment Purchase and Sale -$9.71M $7.97M $2.47M -$36.12M -$27.01M
Financing Cash Flow $146,000.00 -$11.34M -$11.33M -$45.20M -$11.33M
Net Cash Flow from Continuing Financing Activities $146,000.00 -$11.34M -$11.33M -$45.20M -$11.33M
Net Issuance Payments Of Debt $0.00 -$11.12M -$11.11M -$44.44M -$11.11M
Proceeds from Stock Option Exercised $146,000.00 – – $130,000.00 $0.00
Net Other Financing Charges $0.00 -$223,000.00 -$222,000.00 -$888,000.00 -$222,000.00
Ending Cash Balance $41.55M $36.54M $38.28M $31.73M $31.73M
Net Change in Cash $5.01M -$1.75M $6.56M -$39.58M -$23.89M
Beginning Cash Balance $36.54M $38.28M $31.73M $71.31M $55.62M
Free Cash Flow $14.58M $1.62M $15.42M $41.73M $14.46M
Deferred Tax – – – $3.25M –
Net Intangibles Purchase and Sale – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on PBYI.

Sign in to join the discussion.

Scroll to Top